Matthew HARDY

Person

Parkville, AU

People

Patents Grantslast 30 patents

Information Patent Grant
Nucleic acids encoding antibodies against human granulocyte-colony...
- Patent number 12,071,484
- Issue date Aug 27, 2024
- CSL LIMITED
- Andrew Donald Nash
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD131 binding proteins and uses thereof
- Patent number 11,840,573
- Issue date Dec 12, 2023
- CSL LIMITED
- Catherine Owczarek
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD131 binding proteins
- Patent number 10,894,834
- Issue date Jan 19, 2021
- CSL Limited
- Catherine Owczarek
- G01 - MEASURING TESTING
Information Patent Grant
Mutated truncated von Willebrand Factor
- Patent number 10,806,774
- Issue date Oct 20, 2020
- CSL BEHRING LENGNAU AG
- Arna Andrews
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mutated von Willebrand factor
- Patent number 10,808,023
- Issue date Oct 20, 2020
- CSL BEHRING LENGNAU AG
- Arna Andrews
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fibronectin III domain of IL-11Rα
- Patent number 9,796,782
- Issue date Oct 24, 2017
- CSL Limited
- Kirsten Edwards
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
IL-11R binding proteins
- Patent number 9,340,618
- Issue date May 17, 2016
- CSL Limited
- Kirsten Edwards
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies against G-CSFR and uses thereof
- Patent number 9,193,793
- Issue date Nov 24, 2015
- CSL Limited
- Andrew Donald Nash
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CD131 BINDING PROTEINS AND USES THEREOF
- Publication number 20240174757
- Publication date May 30, 2024
- CSL LIMITED
- Catherine OWCZAREK
- G01 - MEASURING TESTING
Information Patent Application
Complement C2 Binding Proteins and Uses Thereof
- Publication number 20220332804
- Publication date Oct 20, 2022
- CSL Innovation Pty Ltd
- Matthew Hardy
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Soluble Complement Receptor Type 1 Variant Conjugates and Uses Thereof
- Publication number 20220305133
- Publication date Sep 29, 2022
- CSL Innovation Pty., Ltd.
- Matthew Hardy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD131 BINDING PROTEINS AND USES THEREOF
- Publication number 20210324091
- Publication date Oct 21, 2021
- CSL Limited
- Catherine OWCZAREK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLUBLE COMPLEMENT RECEPTOR TYPE I VARIANTS AND USES THEREOF
- Publication number 20210238238
- Publication date Aug 5, 2021
- CSL Limited
- Matthew HARDY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST G-CSFR AND USES THEREOF
- Publication number 20210009701
- Publication date Jan 14, 2021
- CSL Limited
- Andrew Donald Nash
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGENTS THAT NEUTRALIZE IL-3 SIGNALLING AND USES THEREOF
- Publication number 20190185573
- Publication date Jun 20, 2019
- CSL Limited
- Nicholas WILSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD131 BINDING PROTEINS AND USES THEREOF
- Publication number 20190062438
- Publication date Feb 28, 2019
- CSL Limited
- Catherine OWCZAREK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AGAINST G-CSFR AND USES THEREOF
- Publication number 20190055313
- Publication date Feb 21, 2019
- CSL Limited
- Andrew Donald Nash
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MUTATED VON WILLEBRAND FACTOR
- Publication number 20190016784
- Publication date Jan 17, 2019
- CSL Behring Recombinant Facility AG
- Arna ANDREWS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MUTATED TRUNCATED VON WILLEBRAND FACTOR
- Publication number 20190015483
- Publication date Jan 17, 2019
- CSL BEHRING RECOMBINANT FACILITY AG
- Arna ANDREWS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI IL-3R ALPHA AGENTS AND USES THEREOF
- Publication number 20180244786
- Publication date Aug 30, 2018
- CSL Limited
- Angel Francisco LOPEZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGENTS THAT NEUTRALIZE IL-3 SIGNALLING AND USES THEREOF
- Publication number 20180208661
- Publication date Jul 26, 2018
- CSL Limited
- Nicholas WILSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AGAINST G-CSFR AND USES THEREOF
- Publication number 20170226214
- Publication date Aug 10, 2017
- CSL Limited
- Andrew Donald Nash
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGENTS THAT NEUTRALIZE IL-3 SIGNALLING AND USES THEREOF
- Publication number 20160046718
- Publication date Feb 18, 2016
- CSL Limited
- Nicholas WILSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AGAINST G-CSFR AND USES THEREOF
- Publication number 20160031998
- Publication date Feb 4, 2016
- CSL Limited
- Andrew Donald Nash
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI IL-3R ALPHA AGENTS AND USES THEREOF
- Publication number 20160031996
- Publication date Feb 4, 2016
- CSL Limited
- Angel Francisco LOPEZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-11R BINDING PROTEINS
- Publication number 20160031999
- Publication date Feb 4, 2016
- 45 Poplar Road
- Kirsten EDWARDS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-11R BINDING PROTEINS AND USES THEREOF
- Publication number 20140219919
- Publication date Aug 7, 2014
- CSL Limited
- Kirsten EDWARDS
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES AGAINST G-CSFR AND USES THEREOF
- Publication number 20120321630
- Publication date Dec 20, 2012
- CSL Limited
- Andrew Donald NASH
- C07 - ORGANIC CHEMISTRY

Matthew HARDY

Person

Patents Grantslast 30 patents

Nucleic acids encoding antibodies against human granulocyte-colony...

CD131 binding proteins and uses thereof

CD131 binding proteins

Mutated truncated von Willebrand Factor

Mutated von Willebrand factor

Fibronectin III domain of IL-11Rα

IL-11R binding proteins

Antibodies against G-CSFR and uses thereof

Patents Applicationslast 30 patents

CD131 BINDING PROTEINS AND USES THEREOF

Complement C2 Binding Proteins and Uses Thereof

Soluble Complement Receptor Type 1 Variant Conjugates and Uses Thereof

CD131 BINDING PROTEINS AND USES THEREOF

SOLUBLE COMPLEMENT RECEPTOR TYPE I VARIANTS AND USES THEREOF

ANTIBODIES AGAINST G-CSFR AND USES THEREOF

AGENTS THAT NEUTRALIZE IL-3 SIGNALLING AND USES THEREOF

CD131 BINDING PROTEINS AND USES THEREOF

ANTIBODIES AGAINST G-CSFR AND USES THEREOF

MUTATED VON WILLEBRAND FACTOR

MUTATED TRUNCATED VON WILLEBRAND FACTOR

ANTI IL-3R ALPHA AGENTS AND USES THEREOF

AGENTS THAT NEUTRALIZE IL-3 SIGNALLING AND USES THEREOF

ANTIBODIES AGAINST G-CSFR AND USES THEREOF

AGENTS THAT NEUTRALIZE IL-3 SIGNALLING AND USES THEREOF

ANTIBODIES AGAINST G-CSFR AND USES THEREOF

ANTI IL-3R ALPHA AGENTS AND USES THEREOF

IL-11R BINDING PROTEINS

IL-11R BINDING PROTEINS AND USES THEREOF

ANTIBODIES AGAINST G-CSFR AND USES THEREOF